| 今开：0.282 | 昨收：0.2958 |
| 最高：0.2981 | 最低：0.2813 |
| 涨停价：0.0 | 跌停价：0.0 |
| 总市值：1.5533408E7 |
BiomX(PHGE)04-16 07:35
$BiomX(PHGE)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0001213900-24-033092 Size: 3 KB 网页链接查看全文
BiomX(PHGE)04-16 05:25
$BiomX(PHGE)$ 8-K Current report, items 5.02, 5.03, and 9.01 Accession Number: 0001213900-24-033032 Act: 34 Size: 449 KB 网页链接查看全文
BiomX(PHGE)04-04 19:55
$BiomX(PHGE)$ S-8 Securities to be offered to employees in employee benefit plans Accession Number: 0001213900-24-030067 Act: 33 Size: 115 KB 网页链接查看全文
动脉网04-04 08:16
今年3月6日，以色列噬菌体疗法企业BiomX（纽约证券交易所美国代码：PHGE） 宣布与美国噬菌体企业Adaptive Phage Therapeutics（APT）达成最终合并协议，以创建一家全新的生物技术公司。新公司仍将名为 BiomX，BiomX 公司现有股东将持有合并后公司 55% 的股份，其余 45% 由 APT 的股东持有。
...查看全文
BiomX(PHGE)04-01 20:35
$BiomX(PHGE)$ D Notice of Exempt Offering of Securities, item 06b Accession Number: 0001213900-24-028241 Act: 33 Size: 15 KB 网页链接查看全文
BiomX(PHGE)04-02 04:05
$BiomX(PHGE)$ NT 10-K Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 Accession Number: 0001213900-24-028708 Act: 34 Size: 29 KB 网页链接查看全文
BiomX(PHGE)04-04 18:35
$BiomX(PHGE)$ 10-K Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0001213900-24-030053 Act: 34 Size: 8 MB 网页链接查看全文
BiomX(PHGE)04-03 19:45
$BiomX(PHGE)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001213900-24-029582 Act: 34 Size: 335 KB 网页链接查看全文
BiomX(PHGE)03-26 03:45
$BiomX(PHGE)$ SC 13G Statement of acquisition of beneficial ownership by individuals Accession Number: 0001104659-24-038400 Act: 34 Size: 108 KB 网页链接查看全文
BiomX(PHGE)03-22 04:35
$BiomX(PHGE)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0001213900-24-024773 Size: 3 KB 网页链接查看全文
$BiomX(PHGE)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0001213900-24-033092 Size: 3 KB 网页链接
$BiomX(PHGE)$ 8-K Current report, items 5.02, 5.03, and 9.01 Accession Number: 0001213900-24-033032 Act: 34 Size: 449 KB 网页链接
$BiomX(PHGE)$ S-8 Securities to be offered to employees in employee benefit plans Accession Number: 0001213900-24-030067 Act: 33 Size: 115 KB 网页链接
$BiomX(PHGE)$ 10-K Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0001213900-24-030053 Act: 34 Size: 8 MB 网页链接
$BiomX(PHGE)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001213900-24-029582 Act: 34 Size: 335 KB 网页链接
$BiomX(PHGE)$ NT 10-K Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 Accession Number: 0001213900-24-028708 Act: 34 Size: 29 KB 网页链接
$BiomX(PHGE)$ D Notice of Exempt Offering of Securities, item 06b Accession Number: 0001213900-24-028241 Act: 33 Size: 15 KB 网页链接
$BiomX(PHGE)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0000950170-24-036452 Size: 9 KB 网页链接
$BiomX(PHGE)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001193125-24-077644 Act: 34 Size: 48 KB 网页链接
$BiomX(PHGE)$ SC 13G Statement of acquisition of beneficial ownership by individuals Accession Number: 0001104659-24-038400 Act: 34 Size: 108 KB 网页链接